Neogen Corporation Lease, Cost
Neogen Corporation (NEOG) reported Lease, Cost of $6.30 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-07-30
- Neogen Corporation lease, cost for the quarter ending 2021-05-31 was $393.00K, a 3.97% increase year-over-year.
- Neogen Corporation lease, cost for the quarter ending 2021-02-28 was $389.00K, a 14.08% increase year-over-year.
- Neogen Corporation lease, cost for the quarter ending 2020-11-30 was $456.00K, a 24.25% increase year-over-year.
- Neogen Corporation lease, cost for the quarter ending 2020-08-31 was $249.00K, a 13.54% decline year-over-year.
- Neogen Corporation lease, cost for fiscal 2026 was $6.30M, a 12.50% decline from fiscal 2025.
- Neogen Corporation lease, cost for fiscal 2025 was $7.20M, a 34.18% increase from fiscal 2024.
- Neogen Corporation lease, cost for fiscal 2024 was $5.37M, a 109.86% increase from fiscal 2023.
- Neogen Corporation lease, cost for fiscal 2023 was $2.56M, a 257.62% increase from fiscal 2022.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | $6.30M 10-K · filed 2026-07-30 | ||||
| 2025-05-31 | $7.20M 10-K · filed 2026-07-30 | $7.23M 10-K · filed 2025-07-30 | |||
| 2024-05-31 | $5.37M 10-K · filed 2025-07-30 | ||||
| 2023-05-31 | $2.56M 10-K · filed 2024-07-30 | ||||
| 2022-05-31 | $715.00K 10-K · filed 2023-08-15 | ||||
| 2021-05-31 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | $782.00K derived: sum of 2 quarters · filed 2022-07-27 | $1.24M derived: sum of 3 quarters · filed 2022-07-27 | $1.49M 10-K · filed 2022-07-27 | |
| 2021-02-28 | $389.00K 10-Q · filed 2021-03-31 | $845.00K derived: sum of 2 quarters · filed 2021-03-31 | $1.09M 10-Q · filed 2021-03-31 | $1.47M derived: sum of 4 quarters · filed 2021-07-30 | |
| 2020-11-30 | $456.00K 10-Q · filed 2020-12-29 | $705.00K 10-Q · filed 2020-12-29 | $1.08M derived: sum of 3 quarters · filed 2021-07-30 | $1.42M derived: sum of 4 quarters · filed 2021-07-30 | |
| 2020-08-31 | $249.00K 10-Q · filed 2020-09-30 | $627.00K derived: sum of 2 quarters · filed 2021-07-30 | $968.00K derived: sum of 3 quarters · filed 2021-07-30 | $1.33M derived: sum of 4 quarters · filed 2021-07-30 | |
| 2020-05-31 | $378.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | $719.00K derived: sum of 2 quarters · filed 2021-07-30 | $1.09M derived: sum of 3 quarters · filed 2021-07-30 | $1.37M 10-K · filed 2021-07-30 | |
| 2020-02-29 | $341.00K 10-Q · filed 2021-03-31 | $708.00K derived: sum of 2 quarters · filed 2021-03-31 | $995.00K 10-Q · filed 2021-03-31 | ||
| 2019-11-30 | $367.00K 10-Q · filed 2020-12-29 | $654.00K 10-Q · filed 2020-12-29 | |||
| 2019-08-31 | $288.00K 10-Q · filed 2020-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |